e-learning
resources
Munich 2006
Monday 04.09.2006
Clinical features of sarcoidosis and other granolomatous disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
BALF cell differential, lymphocyte subsets and lung function correlation in connective tissue or collagen vascular disease with pulmonary involvement
D. Papakosta, K. Manika, G. Kyriazis, T. Kontakiotis, N. Manolakoglou, P. Argyropoulou, D. Gioulekas, D. Bouros, D. Patakas (Exochi, Thessaloniki, Greece)
Source:
Annual Congress 2006 - Clinical features of sarcoidosis and other granolomatous disorders
Session:
Clinical features of sarcoidosis and other granolomatous disorders
Session type:
Electronic Poster Discussion
Number:
3124
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Papakosta, K. Manika, G. Kyriazis, T. Kontakiotis, N. Manolakoglou, P. Argyropoulou, D. Gioulekas, D. Bouros, D. Patakas (Exochi, Thessaloniki, Greece). BALF cell differential, lymphocyte subsets and lung function correlation in connective tissue or collagen vascular disease with pulmonary involvement. Eur Respir J 2006; 28: Suppl. 50, 3124
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009
Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases
Source: Eur Respir J, 55 (2) 1900460; 10.1183/13993003.00460-2019
Year: 2020
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Immunohistochemical analysis of T lymphocytes (TLs) in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) suggests potential role of CD
8+
TLs in lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
a
E
b7
integrin (CD103-
b7
) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
Source: Eur Respir J 2007; 30: Suppl. 51, 576s
Year: 2007
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006
Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 745s
Year: 2006
Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Source: Eur Respir J 2005; 25: 139-146
Year: 2005
Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007
Comparison of peripheral lung and airway tissue inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Bleomycin induces cellular senescence in alveolar epithelial cells
Source: Eur Respir J 2003; 22: 436-443
Year: 2003
The eosinophilic infiltration of lung cancer tissue and its relationship with the expression of IL-5
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
A clinicopathological review of interstitial pneumonia with marked IgG
4
positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Collagen V nasal tolerance reverts pulmonary immune cells proliferation and interstitium remodeling in experimental scleroderma
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept